Preliminary results of a Cancer Research UK phase I trial combining the dinitrobenzamide prodrug CB1954 (tretazicar) and the NQO2 substrate EP-0152R (caricotamide) door Sarker, D, Anderson, D, Spanswick, V, Davies, S, Agarwal, R, Aitken, G, Kerr, D, Hartley, J, Judson, I, Middleton, MR

Quinone oxidoreductase-2-mediated prodrug cancer therapy. door Middleton, MR, Knox, R, Cattell, E, Oppermann, U, Midgley, R, Ali, R, Auton, T, Agarwal, R, Anderson, D, Sarker, D, Judson, I, Osawa, T, Spanswick, V, Davies, S, Hartley, J, Kerr, D

A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases door Plummer R, Greystoke A, Naylor G, Sarker D, Anam ANMK, Prenen H, Teuwen LA, Van Cutsem E, Dekervel J, Haugk B, Ness T, Bhoi S, Jensen M, Morris T, Baumann P, Sjögren N, Tunblad K, Wallberg H, Öberg F, Evans TRJ

Volledige tekst